More cuts could create supply “tipping point”

The Generic and Biosimilar Medicines Association says further price cuts could undermine the supply of medicines The Generic and Biosimilar Medicines Association (GBMA) has warned that if the price cuts proposed in the Grattan Institute report are adopted, the reliable supply of affordable and high-quality PBS medicines would be placed at risk. The organisation also points